Tag: biotech

Incannex and the Next Test for Psychedelic Medicine

by Psychedelics.Media Team

October 6, 2026

As psychedelic medicine moves towards pharmaceutical development, Incannex is attempting to take synthetic psilocybin through the clinical, regulatory and commercial ...

No Result

View All Result

Home
News
Business
Policy & Regulation
Research
Health & Therapy
Opinion
Contact

Not enough quota to unlock this post

Unlock left : 0

Tag: biotech

Incannex and the Next Test for Psychedelic Medicine

Newsletter

Stay Ahead of Psychedelic Medicine

Recommended

Cannabis Built the Clinics. Psychedelics Could Change What They Become.

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

Popular Story

Incannex and the Next Test for Psychedelic Medicine

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

The Global Psychedelic Medicine Conference & Events Calendar 2026–2027

Eli Lilly Reportedly Nears Acquisition of AtaiBeckley in Potential Landmark Deal for Psychedelic Medicine

AbbVie’s $906M Psychedelic Bet: What It Means for Psychedelic Medicine

Recent Posts

Categories

Free Weekly Newsletter

Not enough quota to unlock this post

Are you sure want to cancel subscription?